Paper16612464
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW and 4 others. Braz J Med Biol Res, 2006. Cited by 273 papers, by iCite.
Cite this record
ConductScience Library. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Papers, record 16612464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16612464
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Antipsychotic Agents | Major topic |
| Cannabidiol | Major topic |
| Cannabis | Major topic |
| Schizophrenia | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Disease Models, Animal | |
| Humans | |
| Mental Disorders | |
| Mice | |
| Rats |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04406948 | Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies | Background | ClinicalTrials.gov | |
| NCT06218056 | Cannabidiol for Reducing Cigarette Use | Background | ClinicalTrials.gov |
Cited by120
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 273 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42622700 | Low-Dose Cannabidiol Treatment does not Alter Cognitive Performance in the HIV-1 Transgenic Rat Model of NeuroHIV. | J Neuroimmune Pharmacol | 2026 | https://conductscience.org/library/papers/42622700 | PubMed |
| 42404720 | Phytomedicines in preclinical and clinical research on antipsychotics-induced EPS/EPS-like behaviors: therapeutic effects and neurobiological mechanisms. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42404720 | PubMed |
| 42047775 | Cannabidiol for the treatment of positive and negative symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/42047775 | PubMed |
| 41369966 | Unraveling Cannabidiol's Dual Modulatory Role in Schizophrenia: Network Pharmacology and In Vivo Validation of Neuroinflammatory and Behavioral Modulation. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41369966 | PubMed |
| 40864738 | Molecular Crosstalk and Therapeutic Synergy: Tyrosine Kinase Inhibitors and Cannabidiol in Oral Cancer Treatment. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40864738 | PubMed |
| 40163146 | Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy. | Psychopharmacology (Berl) | 2025 | https://conductscience.org/library/papers/40163146 | PubMed |
| 40032878 | A long road ahead to reliable and complete medicinal plant genomes. | Nat Commun | 2025 | https://conductscience.org/library/papers/40032878 | PubMed |
| 39987154 | Evaluation of cannabidiol-based products in Brazil: how can current regulations influence their labeling quality? | J Cannabis Res | 2025 | https://conductscience.org/library/papers/39987154 | PubMed |
| 38849155 | The Development of Cannabinoids as Therapeutic Agents in the United States. | Pharmacol Rev | 2024 | https://conductscience.org/library/papers/38849155 | PubMed |
| 38482521 | How Precise are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38482521 | PubMed |
| 38418942 | Characterization of indigenous populations of cannabis in Iran: a morphological and phenological study. | BMC Plant Biol | 2024 | https://conductscience.org/library/papers/38418942 | PubMed |
| 38196922 | Does cannabis affect cognitive functioning in patients with schizophrenia? | Schizophr Res Cogn | 2024 | https://conductscience.org/library/papers/38196922 | PubMed |
| 37692969 | Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder. | Am J Transl Res | 2023 | https://conductscience.org/library/papers/37692969 | PubMed |
| 37132109 | Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease. | Curr Drug Res Rev | 2024 | https://conductscience.org/library/papers/37132109 | PubMed |
| 37009000 | Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation. | Front Behav Neurosci | 2023 | https://conductscience.org/library/papers/37009000 | PubMed |
| 36946485 | Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review. | Curr Neuropharmacol | 2023 | https://conductscience.org/library/papers/36946485 | PubMed |
| 36671547 | Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review. | Biomolecules | 2023 | https://conductscience.org/library/papers/36671547 | PubMed |
| 36636553 | How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases. | Ther Adv Chronic Dis | 2023 | https://conductscience.org/library/papers/36636553 | PubMed |
| 36555480 | Real-Time Monitoring of the Cytotoxic and Antimetastatic Properties of Cannabidiol in Human Oral Squamous Cell Carcinoma Cells Using Electric Cell-Substrate Impedance Sensing. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555480 | PubMed |
| 35327432 | Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327432 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16612464
GET https://conductscience.org/api/papers/v1/16612464/cited_by?page=2